Back to company

SCANPHARM A/S: Financial statements 2017

CVR: 16279099

SCANPHARM A/S (CVR 16279099) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 19,072,265 and a net result of DKK -228,236 compared with DKK 1,267,088 the year before. That is a decrease of 2.8% compared with the year before. Equity amounted to DKK 12,743,369. The solvency ratio was 30.7%. The company had 43 employees in the financial year.

Gross Profit
19,072,265 kr.
Profit/Loss
-228,236 kr.
Equity
12,743,369 kr.
Total Assets
41,491,749 kr.
Employees
43

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-19.1 mio.-228 t.12.7 mio.43
2016-19.6 mio.1.3 mio.13 mio.42
2015-20.4 mio.716 t.11.7 mio.42
2014-20.8 mio.431 t.11 mio.-
2013-20.9 mio.400 t.10.6 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like SCANPHARM A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2017

SCANPHARM A/S: The 2016 annual report is outJun 2, 2017

SCANPHARM A/S has published its annual report for 2016. Gross profit came to DKK 19,626,649, and the net result was DKK 1,267,088.

About SCANPHARM A/S

SCANPHARM A/S is a Danish company of the type Aktieselskab based in Birkerød, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SCANPHARM A/S AF 1992 and A/S SCANPHARM AF 1992. The management consists of Andreas Bjørn Jensen. The company is owned by CHLOPETHAN A/S and Peluli Holding ApS. The company has 51 employees. In 2025, the company reported a gross profit of DKK 29,716,677 and a net result of DKK 962,722 compared with DKK 582,684 the year before. Equity amounted to DKK 3,045,406.